Non-coding and intergenic genetic variants of human arylamine n -acetyltransferase 2 (nat2) gene are associated with differential plasma lipid and cholesterol levels and cardiometabolic disorders

HIGHLIGHTS

• who: GWAS et al. from the University of Extremadura, Spain have published the Article: Non-coding and intergenic genetic variants of human arylamine N -acetyltransferase 2 (NAT2) gene are associated with differential plasma lipid and cholesterol levels and cardiometabolic disorders, in the Journal: (JOURNAL)
• what: The authors propose that human NAT2 represents a novel genetic factor that influences plasma lipid and cholesterol levels and, ultimately, alters the risk of cardiometabolic disorders.
• future: The question of how non-coding intergenic variants alter NAT2 expression or activity is of high interest and subject to future . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.